Patents

Implantable Device Has Hyaluronic Acid

US Patent No. 11,154,484 B2 awarded to Allergan Holdings France.

US Patent No. 11,154,484 B2 (Geoffrey C. Gurtner, Kenneth N. Horne, Jayakumar Rajadas); Allergan Holdings France S.A.S., Courbevoie, France, has patented an implantable device comprising a thread comprising uncrosslinked hyaluronic acid or salts, hydrates or solvates thereof and crosslinked hyaluronic acid or salts, hydrates or solvates thereof.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters